Oncology Imaging

Major healthcare organizations, including branches of the National Institutes of Health (NIH), have launched a $26.5 million study to investigate the genetic and socioeconomic factors surrounding black men’s increased susceptibility to more aggressive forms of prostate cancer, according to an NIH release.

Liver cancer death rates among adults continue to climb across the U.S., according to new research from the Centers for Disease Control and Prevention (CDC).

Multiparametric MRI can be a valuable tool for visualizing prostate changes and monitoring patients after MRI-guided focal laser ablation (FLA), according to a July 10 American Journal of Roentgenology study.

Delaware's cancer mortality rate decreased 12 percent from 2010 to 2014 due to state-wide screening efforts and early detection, according to a new Division of Public Health (DPH) report. The state's rate still remains below the 14 percent national average.

High-risk lung cancer patients with prior negative CT screening results have a high prevalence for the disease years later and should continue to be screened even three years after initial tests.

A recent Chicago Tribune article, citing a University of Illinois at Urbana-Champaign study, found segregation increased black women's rates of late-stage breast cancer diagnoses and doubled odds of death.

The U.S. Department of Veterans Affairs (VA) and the National Cancer Institute (NCI) are partnering to extend veterans’ access to clinical trials of novel cancer treatments, according to a National Institutes of Health (NIH) news release.

Heat-sensitive lipid capsules packed with chemotherapy, which can be remotely popped using ultrasound, increased the amount of chemotherapy delivered directly to liver tumors, according to a 10-person study published in The Lancet Oncology.

IBM Watson Health and medical imaging contrast agent company Guerbet have entered a strategic partnership to develop artificial intelligence (AI) software to support liver cancer diagnostics and care by utilizing CT and MRI technology.

A deep learning algorithm deployed at MD Anderson Cancer Center in Houston successfully automated and standardized clinical target volumes (CTVs) for radiation therapy in head and neck cancer patients.

Researchers from Mount Sinai in New York have pinpointed a new biomarker that may ultimately provide individualized treatment in patients with an aggressive form of bladder cancer.

University of Kansas (KU) Cancer Center researchers have launched a clinical trial eliminating radiation therapy from treatment for the invasive type of breast cancer that affects nearly a fifth of all breast cancer patients, according to a KU news release.